跳至主要内容
临床试验/JPRN-jRCT1030230057
JPRN-jRCT1030230057
进行中(未招募)
未知

Elucidation of the association between sarcopenia and accumulated risks of cerebrovascular disease and its predictive factors in patients with type 2 diabetes mellitus - S-ROAD2 study

Kusakabe Toru0 个研究点目标入组 450 人2023年4月29日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
Kusakabe Toru
入组人数
450
状态
进行中(未招募)
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年4月29日
结束日期
待定
最后更新
2年前
研究类型
Observational
性别
All

研究者

发起方
Kusakabe Toru

入排标准

入选标准

  • Patients who satisfy all of the following criteria.
  • (1\) Type 2 diabetes
  • (2\) Lower age limit: 20 years old
  • (3\) Gender: male and female
  • (4\) Outpatients visiting hospitals of the National Hospital Organization
  • (5\) Patients who have provided written informed consent

排除标准

  • Patients who fall under any of the following criteria.
  • (1\) Patients with AST or ALT above 100 U/L
  • (2\) Patients with Cre above 3\.0 mg/dL
  • (3\) Female patients who are suspected of being pregnant or pregnant
  • (4\) Patients with previous history of angioplasty and bypass surgery, history of hospitalization for heart failure treatment within the past one year
  • (5\) Patients with cancer with a history or treatment within five years
  • (6\) Patients taking corticosteroids
  • (7\) Patients with defects in their limbs
  • (8\) Patients wearing pacemakers
  • (9\) Patients judged by the investigator/projectleader to be ineligible for other reasons

结局指标

主要结局

未指定

相似试验